Results for pnewmokokkali translation from Maltese to English

polysaccharides pnewmokokkali
pneumococcal polysaccharides

aom pnewmokokkali kollha
all pneumococcal aom

prevenar hu tilqima pnewmokokkali.
prevenar is a pneumococcal vaccine.

synflorix huwa vaċċin pnewmokokkali konjugat.
synflorix is a pneumococcal conjugate vaccine.

polysaccharide pnewmokokkali serotip 11 2.2 µg
pneumococcal polysaccharide serotype 11 2.2 µg

polysaccharide pnewmokokkali serotip 18c1,3 3 mikrogrammi
pneumococcal polysaccharide serotype 18c1,3 3 micrograms

prevenar 13 hu vaċċin pnewmokokkali mogħti lil:
prevenar 13 is a pneumococcal vaccine given to:

polysaccharide pnewmokokkali serotip 11,2 mikrogramma waħda
pneumococcal polysaccharide serotype 11,2 1 microgram

kategorija farmakoterapewtika: tilqim pnewmokokkali, kodiċi atc:
pharmacotherapeutic group: pneumococcal vaccines, atc code:

vaċċin konjugat (adsorbit) ta’ polysaccharide pnewmokokkali
pneumococcal polysaccharide conjugate vaccine (adsorbed)

21, 45) fl- inċidenza tal- aoms pnewmokokkali kollha.
21, 45) reduction in the incidence of all pneumococcal aom.

kategorija farmakoterapewtika: tilqim pnewmokokkali, kodiċi atc: j07al52
pharmacotherapeutic group: pneumococcal vaccines, atc code: j07al52

tilqima konjugata saccharide pnewmokokkali, adsorbita użu għal ġol-muskoli.
pneumococcal saccharide conjugated vaccine, adsorbed intramuscular use.

kategorija farmakoterapewtika: tilqim pnewmokokkali, kodiċi atc: j07al02 immunoġeniċità
pharmacotherapeutic group: pneumococcal vaccines, atc code: j07al02 immunogenicity

kategorija farmakoterapewtika: tilqim, tilqim pnewmokokkali; kodiċi atc: j07al02
pharmacotherapeutic group: vaccines, pneumococcal vaccines; atc code: j07al02

tilqima ta’ konjugat (13 valent, adsorbit) ta’ polysaccharide pnewmokokkali
pneumococcal polysaccharide conjugate vaccine (13 valent, adsorbed)

adulti li preċedentement tlaqqmu bil-vaċċin polisakkaride pnewmokokkali ta’ 23-valenti
adults previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

adulti li tlaqqmu fil-passat b’tilqima polysaccharide pnewmokokkali ta’ 23 valent
adults previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

adulti li ma kinux tlaqqmu qabel bil-vaċċin polisakkaride pnewmokokkali ta’ 23-valenti
adults not previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

42 %), u rati mnaqqsa għall-vaċċin ta’ polysaccharide pnewmokokkali (43 % vs.
42%), reduced rates to pneumococcal polysaccharide vaccine (43% vs.